Lynn Seely Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Lynn Seely is of Blueprint Medicines Corp. Currently has a direct ownership of 13,254 shares of BPMC, which is worth approximately $1.15 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 2,242 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3K
20.36% 3M change
20.36% 12M change
Total Value Held $1.15 Million

Lynn Seely Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
2,242 Added 14.47%
13,254 Common Stock
Jun 21 2023
BUY
Grant, award, or other acquisition
-
2,600 Added 19.1%
11,012 Common Stock
Jun 21 2022
BUY
Grant, award, or other acquisition
-
2,600 Added 23.61%
8,412 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,250 Added 27.91%
5,812 Common Stock

Also insider at

LYEL
Lyell Immunopharma, Inc. Healthcare
President and CEO
LS

Lynn Seely

Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC